On Thursday, July 12, Shares of Vertex Pharmaceuticals Incorporated (VRTX) were valued at $178.27 and moved 1.86% as of a recent closing trade. A total volume of 1.18 million shares were traded versus to average volume of 1.66 million shares.
Vertex Pharmaceuticals Incorporated (VRTX) held 246.43 million outstanding shares currently. The company have shares float of 246.43 million. Now have a look at past performance (weekly performance to year to date performance) how Vertex Pharmaceuticals Incorporated (VRTX) has been moved; whether it performed well or not. VRTX reported a change of 5.18% over the last week and performed 18.07% over the last month while its year to date (YTD) performance revealed an activity trend of 18.96%. The stock’s quarterly performance specifies a shift of 10.06%, and its last twelve month performance is stands at 35.63% while moved 13.27% for the past six months.
52 week High and Low
Vertex Pharmaceuticals Incorporated (VRTX) shares have been seen trading 0.01% off its 52 week- peak value and changed 39.63% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.
Technical analysis of Vertex Pharmaceuticals Incorporated (VRTX) stock includes the study of technical indicators and past trends. For technical analysis of stock and trends here we employ the use of tools such as trading volumes, Simple Moving averages, RSI (14), and ATR (14) to determine the future behavior of a stock. Much of this practice involves discovering the overall trend line of a stock’s movement. Technical analysis of stocks and trends has been used by serious traders for decades. Although it does not guarantee success and is not 100% accurate, it is still one of the two key methods of analyzing stock prices, along with fundamental analysis.
Relative Strength Index (RSI)
Vertex Pharmaceuticals Incorporated (VRTX)’s Relative Strength Index (RSI) is 71.81. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for Vertex Pharmaceuticals Incorporated (VRTX) is stands at 4.60. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.
Over the past week, the company showed volatility of 1.83%. Moving out to look at the previous month volatility move, the stock is at 2.55%.
Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is 1.50.
Analyst mean recommendation rating on a stock by the analyst community is at 1.80. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating.